Abstract
Cancer and cardiovascular (CV) disease are a significant global public health issue and remain the main causes of morbidity and mortality worldwide. Anti-cancer therapy based on cardiotoxic agents such as the anthracyclines (DNA intercalating Topoisomerase II inhibitors) can lead to irreversible damage on cardiomyocytes ultimately causing heart failure. Strong efforts have been made to de…